BOLT
Bolt Biotherapeutics
NASDAQ: BOLT · HEALTHCARE · BIOTECHNOLOGY
$4.87
+2.21% today
Updated 2026-04-30
Market cap
$9.28M
P/E ratio
—
P/S ratio
1.21x
EPS (TTM)
$-17.85
Dividend yield
—
52W range
$4 – $9
Volume
0.0M
Bolt Biotherapeutics (BOLT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | $15.97M | $48.45M | $46.54M | $307.72M | $227.81M | $159.78M | $99.63M |
| Cash & equivalents | $13.63M | $34.83M | $5.54M | $27.38M | $9.24M | $10.81M | $7.21M |
| Current assets | $14.10M | $35.90M | $25.36M | $189.16M | $172.75M | $105.71M | $50.81M |
| Total liabilities | $31.92M | $94.29M | $151.49M | $57.60M | $56.30M | $47.04M | $42.43M |
| Current liabilities | $2.75M | $8.66M | $11.26M | $21.33M | $23.12M | $20.46M | $15.86M |
| Long-term debt | — | — | — | — | — | — | — |
| Shareholder equity | $-15.94M | $-45.85M | $-104.95M | $250.12M | $171.51M | $112.74M | $57.20M |
| Retained earnings | $-17.18M | $-47.67M | $-108.40M | $-206.99M | $-295.09M | $-364.29M | $-427.40M |
| Accounts receivable | — | $300000.00 | $12000.00 | $200000.00 | $800000.00 | $1.30M | $1.17M |
| Inventory | — | $-300000.00 | $-12000.00 | $-200000.00 | $-800000.00 | — | $1.00 |
| Goodwill | — | — | — | — | — | — | — |